Omeros' Epic IPO Voyage Could be Delayed by a Former CFO's Lawsuit
This article was originally published in The Pink Sheet Daily
Executive Summary
The Seattle biotech navigates the recession and resuscitates its IPO, but its former CFO is now a whistleblower and has erected a legal hurdle.